Closing Procedures and Your Business Defense in a Business Merger

Undisclosed environmental liabilities, pending litigation, and tax contingencies are the three categories that most frequently trigger post-closing disputes and buyer regret. Environmental issues are particularly treacherous because they often remain hidden until after closing, and federal law can impose joint and several liability on current owners regardless of when contamination occurred. Tax exposure is equally dangerous: a revenue agent's examination of the target company's prior returns can surface unfiled returns, unclaimed credits, or aggressive positions that the buyer inherits. Litigation risk requires careful review of all pending matters, threatened claims, and settlement agreements that may contain indemnification or assumption obligations. In our experience, buyers who conduct superficial due diligence on these three categories end up in litigation with their own legal counsel within two years.

Allocation happens through indemnification baskets, caps, and survival periods. A basket is a threshold below which the buyer absorbs the loss; a cap limits the seller's total exposure; a survival period defines how long after closing the buyer can bring claims. These mechanics sound mechanical, but they determine whether a one-million-dollar environmental discovery is the buyer's problem or the seller's problem. Sellers push for low baskets and short survival periods; buyers push the opposite. The negotiation reflects the true risk allocation and often reveals which party has more confidence in the due diligence. When these provisions are vague or missing, courts in New York and federal courts applying New York law often interpret them against the drafter, creating additional uncertainty.

Industry-specific licenses, antitrust review by the Federal Trade Commission or Department of Justice, and foreign investment screening (if applicable) are the primary gatekeepers. A buyer in healthcare, financial services, telecommunications, or transportation must verify that all required licenses can be transferred or reissued post-closing. Antitrust risk depends on market share and competitive overlap; deals involving competitors or market consolidation trigger FTC scrutiny and can face extended review or outright challenge. Foreign investment in sensitive sectors may require Committee on Foreign Investment in the United States (CFIUS) approval, which can take months. The transaction timeline must build in realistic approval windows, and the purchase agreement should define what happens if approval is denied or conditioned.

The New York Supreme Court, Appellate Division, First Department handles commercial disputes arising from merger agreements, including claims that regulatory conditions were not satisfied or that one party wrongfully terminated based on alleged approval failure. Practical significance lies in the court's willingness to enforce specific performance (forcing the buyer to close) or to award damages for breach. New York courts generally respect the parties' explicit conditions precedent but scrutinize attempts to use regulatory uncertainty as a pretext for termination. If a party claims the other party failed to use reasonable efforts to obtain approval, the court examines internal communications, meetings with regulators, and whether the party actually submitted required filings on time.

Yes, for deals above approximately ten million dollars, R&W insurance is economically sensible and often required by financing lenders. The policy covers breaches of the seller's representations regarding financial condition, legal compliance, contracts, and title to assets. Coverage typically includes a deductible (the buyer's co-insurance), a sublimit per claim, and an aggregate limit. Exclusions matter enormously: most policies exclude known issues, matters disclosed in due diligence, and breaches arising from changes in law after closing. The buyer pays the premium (usually one and one-half to three percent of the purchase price) and retains the right to claim against the policy. The advantage is that the insurance company, not the seller, is the claims administrator, removing personal animosity and settlement disputes from the process. The disadvantage is that coverage is narrower than a traditional indemnification basket and may not cover every category of loss.

When R&W insurance is in place, the purchase agreement often includes lower indemnification baskets and caps because the insurance backstops excess losses. Sellers benefit because their personal indemnification exposure is capped, and the deal is less likely to generate post-closing disputes. Buyers benefit because they have a reliable recovery mechanism. Both parties should ensure the insurance underwriting is complete before closing and that no material issues discovered during final due diligence are excluded from coverage.

Three priorities stand out. First, confirm that all required third-party consents (from landlords, lenders, customers, and suppliers) will be obtained or that the agreement includes adequate remedies if they are not. Second, verify that the target company's financial statements are accurate and that no material adverse change has occurred since the agreed baseline. Third, ensure that all key employees have signed employment or retention agreements so that the business does not lose critical talent at closing. Courts in New York and federal courts handling merger disputes frequently see disputes arise from failures in any of these three areas. A buyer who discovers weeks before closing that a major customer has a contract clause requiring consent to change of control faces either renegotiation of the purchase price or acceptance of the risk that the customer terminates post-closing.

Asset purchase versus stock purchase is the foundational choice. In an asset purchase, the buyer acquires selected assets and liabilities, leaving behind unknown or unwanted obligations. In a stock purchase, the buyer acquires the entire entity and inherits all liabilities, known and unknown. Asset purchases offer better risk isolation but are slower and more complex. Stock purchases are faster and maintain business continuity but leave the buyer exposed to hidden liabilities. Business acquisition transactions typically involve detailed analysis of this choice, and the decision should be made early in the process, not during final negotiation. Earn-out provisions (where part of the purchase price is contingent on post-closing performance) can align incentives but create ongoing disputes about whether performance targets were met. Business advisory counsel should evaluate whether an earn-out is appropriate for your industry and target company profile.

The forward-looking question is not whether your merger will be complex, but whether you have identified the specific categories of risk that matter most for your transaction. Due diligence, regulatory approval, and allocation of indemnification are not abstract concepts; they determine whether you close on time, at the agreed price, and without inheriting catastrophic liabilities. Begin now by mapping which of these three categories poses the greatest risk for your deal, and ensure that your legal team has adequate time and resources to address it before you commit to closing.